litlas
ログインアカウント作成

David C. Linch

1980–2025 年に発表

119
論文数
28,915
被引用数
89
h 指数
119
i10 指数

被引用数

David C. Linch の年別被引用数1977 年: 被引用 1 件1981 年: 被引用 4 件1982 年: 被引用 2 件1983 年: 被引用 2 件1984 年: 被引用 6 件1985 年: 被引用 25 件1986 年: 被引用 23 件1987 年: 被引用 31 件1988 年: 被引用 16 件1989 年: 被引用 16 件1990 年: 被引用 20 件1991 年: 被引用 14 件1992 年: 被引用 16 件1993 年: 被引用 15 件1994 年: 被引用 22 件1995 年: 被引用 23 件1996 年: 被引用 18 件1997 年: 被引用 33 件1998 年: 被引用 32 件1999 年: 被引用 35 件2000 年: 被引用 60 件2001 年: 被引用 74 件2002 年: 被引用 112 件2003 年: 被引用 171 件2004 年: 被引用 144 件2005 年: 被引用 190 件2006 年: 被引用 172 件2007 年: 被引用 182 件2008 年: 被引用 186 件2009 年: 被引用 207 件2010 年: 被引用 255 件2011 年: 被引用 195 件2012 年: 被引用 240 件2013 年: 被引用 231 件2014 年: 被引用 224 件2015 年: 被引用 224 件2016 年: 被引用 233 件2017 年: 被引用 252 件2018 年: 被引用 181 件2019 年: 被引用 688 件2020 年: 被引用 734 件2021 年: 被引用 680 件2022 年: 被引用 522 件2023 年: 被引用 368 件2024 年: 被引用 528 件2025 年: 被引用 231 件2026 年: 被引用 3 件1978〜1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,165 件、この内訳の 29.8%イギリス: 引用元論文 991 件、この内訳の 9.3%ドイツ: 引用元論文 883 件、この内訳の 8.3%イタリア: 引用元論文 624 件、この内訳の 5.9%フランス: 引用元論文 552 件、この内訳の 5.2%中国: 引用元論文 548 件、この内訳の 5.2%オランダ: 引用元論文 387 件、この内訳の 3.6%カナダ: 引用元論文 362 件、この内訳の 3.4%スペイン: 引用元論文 289 件、この内訳の 2.7%オーストラリア: 引用元論文 288 件、この内訳の 2.7%スイス: 引用元論文 257 件、この内訳の 2.4%日本: 引用元論文 220 件、この内訳の 2.1%
0%29.8%その他 19.4%

機関

分野

  • Medicine71.7%
  • Biochemistry, Genetics and Molecular Biology21.9%
  • Immunology and Microbiology4.4%
  • Neuroscience0.5%
  • Computer Science0.2%
  • Engineering0.2%
  • その他1.1%

トピック

  • Acute Myeloid Leukemia Research8.7%
  • CAR-T cell therapy research6.9%
  • Lymphoma Diagnosis and Treatment6.6%
  • Virus-based gene therapy research4.7%
  • Acute Lymphoblastic Leukemia research3.3%
  • Hematopoietic Stem Cell Transplantation3.3%
  • その他66.5%

共著者

全論文

検索で開く
  1. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    著者: Amit C. Nathwani, Edward G. D. Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C. Linch, Pratima Chowdary, Anne Riddell, Arnulfo Pie, Chris F. Harrington, James O’Beirne, Keith Smith, John Pasi, Bertil Glader, Pradip K. Rustagi, Catherine Y. Ng, Mark A. Kay, Junfang Zhou, Yunyu Spence, Christopher L. Morton, James A. Allay, John B. Coleman, Susan Sleep, John M. Cunningham, Deo Kumar Srivastava, Etiena Basner‐Tschakarjan, Federico Mingozzi, Katherine A. High, John T. Gray, Ulrike M. Reiss, Arthur W. Nienhuis, Andrew M. Davidoff - New England Journal of Medicine 2011 被引用: 1,843

  2. Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

    著者: Christian Gisselbrecht, Bertram Glaß, Nicolas Mounier, Devinder Gill, David C. Linch, Marek Trněný, André Bosly, Nicolas Ketterer, Ofer Shpilberg, Hans Hagberg, Dávid Ma, Josette Brière, Craig H. Moskowitz, Norbert Schmitz - Journal of Clinical Oncology 2010 被引用: 1,622

  3. Assessment of Minimal Residual Disease in Standard-Risk AML

    著者: Adam Ivey, Robert K. Hills, Michael A. Simpson, Jelena Jovanović, Amanda Gilkes, Angela Grech, Yashma Patel, Neesa Bhudia, Hassan Farah, Joanne Mason, Kerry Wall, Susanna Akiki, Mike Griffiths, Ellen Solomon, Frank McCaughan, David C. Linch, Rosemary E. Gale, Paresh Vyas, Sylvie Freeman, Nigel H. Russell, Alan K. Burnett, David Grimwade - New England Journal of Medicine 2016 被引用: 836

  4. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

    著者: Steven J. Howe, Marc R. Mansour, Kerstin Schwarzwaelder, Cynthia C. Bartholomae, Michael Hubank, Helena Kempski, Martijn H. Brugman, Karin Pike‐Overzet, S Chatters, Dick de Ridder, Kimberly Gilmour, Stuart Adams, Susannah I. Thornhill, Kathryn L. Parsley, Frank J. T. Staal, Rosemary E. Gale, David C. Linch, Jinhua Bayford, Lucie Brown, Michelle Quaye, Christine Kinnon, Philip Ancliff, David Webb, Manfred Schmidt, Christof von Kalle, H. Bobby Gaspar, Adrian J. Thrasher - Journal of Clinical Investigation 2008 被引用: 1,282

  5. A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy

    著者: Brian Philip, Evangelia Kokalaki, Leila Mekkaoui, Simon Thomas, Karin Straathof, Barry Flutter, Virna Marin, Teresa Marafioti, Ronjon Chakraverty, David C. Linch, Sergio A. Quezada, Karl S. Peggs, Martin Pulé - Blood 2014 被引用: 401

  6. Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

    著者: Claire Roddie, Juliana Dias, Maeve O’Reilly, Mahnaz Abbasian, Amaia Cadiñanos-Garai, Ketki Vispute, Leticia Bosshard‐Carter, Marina Mitsikakou, Vedika Mehra, Harriet Roddy, John A. Hartley, Victoria J. Spanswick, Helen L. Lowe, Bilyana Popova, Laura Clifton‐Hadley, Graham Wheeler, Joanna Olejnik, Adrian Bloor, David Irvine, L. Wood, Maria A. V. Marzolini, Sabine Domning, Farzin Farzaneh, Mark W. Lowdell, David C. Linch, Martin Pulé, Karl S. Peggs - Journal of Clinical Oncology 2021 被引用: 142

  7. Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies

    著者: Paul Maciocia, Patrycja Wawrzyniecka, Brian Philip, Ida Ricciardelli, Ayse U. Akarca, Shimobi Onuoha, Mateusz Legut, David K. Cole, Andrew K. Sewell, Giuseppe Gritti, Joan Somja, Miguel Á. Piris, Karl S. Peggs, David C. Linch, Teresa Marafioti, Martin Pulé - Nature Medicine 2017 被引用: 283

  8. Acute myeloid leukaemia

    著者: Asim Khwaja, Magnus Björkholm, Rosemary E. Gale, Ross L. Levine, Craig T. Jordan, Gerhard Ehninger, Clara D. Bloomfield, Eli Estey, Alan K. Burnett, Jan J. Cornelissen, David A. Scheinberg, Didier Bouscary, David C. Linch - Nature Reviews Disease Primers 2016 被引用: 587

  9. Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma

    著者: Claire Roddie, Lazaros J. Lekakis, Maria A. V. Marzolini, Aravind Ramakrishnan, Yiyun Zhang, Yanqing Hu, Vijay Peddareddigari, Nushmia Z. Khokhar, Robert W. Chen, Silvia Basilico, Meera Raymond, Frederick Arce Vargas, Kevin Duffy, Wolfram Brugger, Maeve O’Reilly, Leigh Wood, David C. Linch, Karl S. Peggs, Carlos Bachier, Lihua E. Budde, Connie Lee Batlevi, Nancy L. Bartlett, David Irvine, Eleni Tholouli, Wendy Osborne, Kirit M. Ardeshna, Martin Pulé - Blood 2023 被引用: 70

  10. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

    著者: David Cunningham, Eliza A. Hawkes, Andrew Jack, Wendi Qian, Paul Smith, Paul Mouncey, Christopher Pocock, Kirit M. Ardeshna, John Radford, Andrew McMillan, John Davies, Deborah Turner, Anton Kruger, Peter Johnson, Joanna Gambell, David C. Linch - The Lancet 2013 被引用: 556

  11. Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

    著者: Éric Van Den Neste, Norbert Schmitz, Nicolas Mounier, Devinder Gill, David C. Linch, Marek Trněný, Nöel Milpied, John Radford, Nicolas Ketterer, Ofer Shpilberg, Ulrich Dührsen, Dávid Ma, Josette Brière, Catherine Thiéblemont, Gilles Salles, Craig H. Moskowitz, B. Glaß, Christian Gisselbrecht - Bone Marrow Transplantation 2015 被引用: 316

  12. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

    著者: Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew, G Harrison, Stephen E. Langabeer, Andrea A. Belton, Helen M. Walker, Keith Wheatley, David Bowen, Alan K. Burnett, Anthony H. Goldstone, David C. Linch - Blood 2001 被引用: 1,538

  13. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

    著者: Rosemary E. Gale, Claire Green, Christopher Allen, Adam J. Mead, Alan K. Burnett, Robert K. Hills, David C. Linch - Blood 2007 被引用: 744

  14. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

    著者: Kirit M. Ardeshna, Wendi Qian, Paul Smith, Nivette Braganca, Lisa Lowry, Pip Patrick, June Warden, Lindsey Stevens, Christopher Pocock, Fiona Miall, David Cunningham, John Davies, Andrew Jack, Richard Stephens, Jan Walewski, Burhan Ferhanoğlu, Ken Bradstock, David C. Linch - The Lancet Oncology 2014 被引用: 388

  15. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients

    著者: Friederike Christen, Kaja Hoyer, Kenichi Yoshida, Hsin‐An Hou, Nils Waldhueter, Michael Heuser, Robert K. Hills, Willy Chan, Raphael Hablesreiter, Olga Blau, Yotaro Ochi, Piroska Klement, Wen‐Chien Chou, Igor‐Wolfgang Blau, Jih‐Luh Tang, Tomasz Żemojtel, Yuichi Shiraishi, Yusuke Shiozawa, Felicitas Thol, Arnold Ganser, Bob Löwenberg, David C. Linch, Lars Bullinger, Peter J.M. Valk, Hwei‐Fang Tien, Rosemary E. Gale, Seishi Ogawa, Frédérik Damm - Blood 2019 被引用: 139

  16. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial

    著者: Lisa Lowry, Paul Smith, Wendi Qian, Stephen Falk, Kim Benstead, Tim Illidge, David C. Linch, Martin Robinson, Andrew Jack, Peter Hoskin - Radiotherapy and Oncology 2011 被引用: 386

  17. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

    著者: Alvina G. Lai, Laura Pasea, Amitava Banerjee, Geoff Hall, Spiros Denaxas, Wai Hoong Chang, Michail Katsoulis, Bryan Williams, Deenan Pillay, Mahdad Noursadeghi, David C. Linch, Derralynn Hughes, Martin Förster, Clare Turnbull, Natalie Fitzpatrick, Kathryn Boyd, Graham R. Foster, Tariq Enver, Vahé Nafilyan, Ben Humberstone, Richard D Neal, Matt Cooper, Monica Jones, Kathy Pritchard‐Jones, Richard Sullivan, Charlie Davie, Mark Lawler, Harry Hemingway - BMJ Open 2020 被引用: 329

  18. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

    著者: David C. Linch, A. H. Goldstone, Annabel McMillan, Rajesh Chopra, G. Vaughan Hudson, D.A. Winfield, Barry W. Hancock, D. J. Moir, D Milligan - The Lancet 1993 被引用: 1,050

  19. Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia

    著者: Sunniyat Rahman, Michael Magnussen, Theresa E. León, Nadine Farah, Zhaodong Li, Brian J. Abraham, Krisztina Zuborne Alapi, Rachel J. Mitchell, Tom Naughton, Adele K. Fielding, Arnold Pizzey, Sophia Bustraan, Christopher Allen, Teodora Popa, Karin Pike‐Overzet, Laura García-Pérez, Rosemary E. Gale, David C. Linch, Frank J. T. Staal, Richard A. Young, A. Thomas Look, Marc R. Mansour - Blood 2017 被引用: 80

  20. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

    著者: Wei‐Yu Lin, Sarah Fordham, Eric A. Hungate, Nicola J. Sunter, Claire Elstob, Yaobo Xu, Catherine Park, Anne S. Quante, Konstantin Strauch, Christian Gieger, Andrew D. Skol, Thahira Rahman, Lara E. Sucheston‐Campbell, Junke Wang, Theresa Hahn, Alyssa Clay‐Gilmour, Gail Jones, Helen Marr, Graham Jackson, Tobias Menne, Mathew Collin, Adam Ivey, Robert K. Hills, Alan K. Burnett, Nigel H. Russell, Jude Fitzgibbon, Richard A. Larson, Michelle M. Le Beau, Wendy Stock, Olaf Heidenreich, Abrar Alharbi, David Allsup, Richard S. Houlston, Jean Norden, Anne M. Dickinson, Elisabeth Douglas, Clare Lendrem, Ann K. Daly, Louise Palm, Kim Piechocki, Sally Jeffries, Martin Bornhäuser, Christoph Röllig, Heidi Altmann, Leo Ruhnke, Desireé Kunadt, Lisa Wagenführ, Heather J. Cordell, Rebecca Darlay, Mette Klarskov Andersen, Maria Chiara Fontana, Giovanni Martinelli, Giovanni Marconi, Miguel Á. Sanz, José Cervera, Inés Gómez‐Seguí, Thomas Cluzeau, Chimène Moreilhon, Sophie Raynaud, Heinz Sill, Maria Teresa Voso, Francesco Lo‐Coco, Hervé Dombret, Meyling Cheok, Claude Preudhomme, Rosemary E. Gale, David C. Linch, Julia Gaal-Wesinger, András Masszi, Daniel Nowak, Wolf‐Karsten Hofmann, Amanda Gilkes, Kimmo Porkka, Jelena D. Milosevic Feenstra, Róbert Královics, David Grimwade, Manja Meggendorfer, Torsten Haferlach, Szilvia Krizsán, Csaba Bödör, Friedrich Stölzel, Kenan Onel, James M. Allan - Nature Communications 2021 被引用: 43

  21. EZH2 -Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress

    著者: Theresa E. León, Tanya Rapoz-D’Silva, Cosetta Bertoli, Sunniyat Rahman, Michael Magnussen, Brian Philip, Nadine Farah, Simon Richardson, Sara Ahrabi, José Afonso Guerra‐Assunção, Rajeev Gupta, Elisabeth P. Nacheva, Stephen Henderson, Javier Herrero, David C. Linch, Robertus A.M. de Bruin, Marc R. Mansour - Cancer Discovery 2020 被引用: 40

  22. Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

    著者: Christian Gisselbrecht, Norbert Schmitz, Nicolas Mounier, Devinder Gill, David C. Linch, Marek Trněný, André Bosly, Nöel Milpied, John Radford, Nicolas Ketterer, Ofer Shpilberg, Ulrich Dührsen, Hans Hagberg, Daniel David, Andreas Viardot, Ray M. Lowenthal, Josette Brière, Gilles Salles, Craig H. Moskowitz, Bertram Glaß - Journal of Clinical Oncology 2012 被引用: 273

  23. TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis

    著者: David Bowen, Michael J. Groves, Alan K. Burnett, Yashma Patel, Christopher Allen, C Green, Rosemary E. Gale, Robert K. Hills, David C. Linch - Leukemia 2008 被引用: 210

  24. De Novo Treatment of Diffuse Large B-Cell Lymphoma With Rituximab, Cyclophosphamide, Vincristine, Gemcitabine, and Prednisolone in Patients With Cardiac Comorbidity: A United Kingdom National Cancer Research Institute Trial

    著者: Paul Fields, William Townsend, Andrew Webb, Nicholas Counsell, Christopher Pocock, Paul Smith, Andrew Jack, Nadjet El-Mehidi, Peter Johnson, John Radford, David C. Linch, David Cunnningham - Journal of Clinical Oncology 2013 被引用: 101